Does Novartis Pharmaceuticals sponsor H-1B visas?
Yes — NOVARTIS PHARMACEUTICALS CORPORATION filed 280 H-1B and E-3 labor condition applications that the US Department of Labor certified between 1 October 2023 and 30 June 2026, 75 of them in FY2026 (to 30 Jun). It also had 56 PERM labor certifications (the first step of most employer-sponsored green cards) certified in the same period.
NOVARTIS PHARMACEUTICALS CORPORATION
- Certified LCAs, FY2024–FY2026
- 280
- Certified, FY2026 (to 30 Jun)
- 75
- Denied LCAs
- 0
- PERM certified
- 56
- Most-filed title
- Principal Biostatistician
- Its median offered wage
- $136,219
- Employer state on filings
- New Jersey
- Distinct certified titles
- 191
Novartis Pharmaceuticals H-1B filings by fiscal year
Labor condition applications decided in each US fiscal year (1 October to 30 September). FY2026 (to 30 Jun) covers decisions to 30 June 2026 only. Worker positions is the most workers the certified applications may cover, as declared by the employer, not a count of people hired. Some employers file blanket applications covering up to 100 positions each, which inflates this figure.
| Fiscal year | Certified | Certified, later withdrawn | Denied | Withdrawn | Worker positions |
|---|---|---|---|---|---|
| FY2024 | 91 | 0 | 0 | 0 | 91 |
| FY2025 | 114 | 0 | 0 | 0 | 114 |
| FY2026 (to 30 Jun) | 75 | 0 | 0 | 0 | 75 |
| Total | 280 | 0 | 0 | 0 | 280 |
What Novartis Pharmaceuticals pays sponsored workers
Every labor condition application names a prevailing-wage level from the Department of Labor's wage survey: level I is entry level, II qualified, III experienced and IV fully competent. "No level" means the employer set the prevailing wage from another source, such as a private survey or a union contract. Counts are Novartis Pharmaceuticals's 280 certified LCAs decided between 1 October 2023 and 30 June 2026 (FY2024–FY2026; latest decision in the data 30 June 2026). Wages are the offered "rate of pay from", annualised, not actual pay.
| Wage level | Share of certified LCAs | Certified LCAs | Median offered wage |
|---|---|---|---|
| Level Ientry | 5% | 14 | $96,668 |
| Level IIqualified | 21% | 60 | $112,965 |
| Level IIIexperienced | 37% | 104 | $141,170 |
| Level IVfully competent | 36% | 100 | $169,541 |
| No levelother wage source | 1% | 2 | $160,856 |
| All levels | 100% | 280 |
The most common level is III (experienced), at 37% of certified LCAs. Its median offered wage is $141,170 a year. The job-title table below shows the level mix for each of the 15 most-filed titles.
Novartis Pharmaceuticals H-1B salaries by job title
The 15 most-filed of 191 distinct job titles on certified LCAs. Wages are the offered "rate of pay from" on each application, annualised (hourly × 2,080), not actual pay. "Middle 50%" is the 25th to 75th percentile. Under each title is the share of its certified LCAs at wage levels I to IV (shaded light to dark) and with no level.
| Job title as filedand its wage-level mix | Certified filings | Median wage | Middle 50% |
|---|---|---|---|
| Principal BiostatisticianII 41% · III 53% · IV 6% | 32 | $136,219 | $113k–$143k |
| Senior Principal BiostatisticianII 29% · III 57% · IV 14% | 14 | $136,219 | $117k–$141k |
| Expert Science & TechnologyII 33% · III 67% | 6 | $113,433 | $109k–$115k |
| Associate Expert Science & TechnologyI 75% · II 25% | 4 | $71,490 | $70k–$75k |
| Senior Principal Product Service ManagerIII 25% · IV 75% | 4 | $128,960 | $128k–$129k |
| Associate Director BiostatisticianIII 67% · IV 33% | 3 | $142,771 | $143k–$155k |
| Operational Health Project ManagerII 33% · III 67% | 3 | $129,709 | $126k–$140k |
| Associate Clinical Development Medical DirectorIII 50% · IV 50% | 2 | $156,281 | $137k–$176k |
| Associate Director Patient Marketing VijoiceII 100% | 2 | $156,967 | $157k–$157k |
| Associate Director, BiostatisticsIV 100% | 2 | $175,781 | $176k–$176k |
| Associate Director, Business Applications Product OwnerIII 100% | 2 | $126,818 | $127k–$127k |
| Associate Director, Commercial AnalyticsIII 50% · IV 50% | 2 | $152,204 | $147k–$158k |
| Associate Director, Manufacturing SystemsIV 100% | 2 | $127,067 | $124k–$130k |
| Associate Director, NPS Enterprise AnalyticsIV 100% | 2 | $170,373 | $170k–$170k |
| Associate Director, Reporting and Business InsightsII 50% · IV 50% | 2 | $163,124 | $163k–$163k |
Where the jobs are
Worksite state on certified LCAs (top 7).
| Worksite state | Certified filings |
|---|---|
| New Jersey | 255 |
| Massachusetts | 17 |
| North Carolina | 3 |
| California | 2 |
| Arizona | 1 |
| Georgia | 1 |
| Michigan | 1 |
Visa classes
All LCA filings by visa class, any status. H-1B1 is for citizens of Chile and Singapore; E-3 for Australians.
| Visa class | Filings |
|---|---|
| H-1B | 277 |
| E-3 Australian | 3 |
Does Novartis Pharmaceuticals sponsor green cards?
It also had 56 PERM labor certifications (the first step of most employer-sponsored green cards) certified in the same period. A certified PERM application means the Department of Labor accepted the employer's labor-market test; the worker still needs an approved I-140 petition and a green card from USCIS.
| Fiscal year | Certified | Denied | Withdrawn |
|---|---|---|---|
| FY2024 | 16 | 0 | 0 |
| FY2025 | 22 | 0 | 0 |
| FY2026 (to 30 Jun) | 18 | 0 | 0 |
| PERM job title | Certified | Median wage |
|---|---|---|
| Principal Biostatistician | 7 | $150,350 |
| AD, Data Scientist | 3 | $163,238 |
| Associate Director, PSS Insights & Decision Science | 2 | $172,000 |
| Director, Predictive Analytics Solutions | 2 | $207,480 |
| Expert Science & Technology | 2 | $121,691 |
| Medical Science Liaison, Director | 2 | $226,470 |
| AD Commercial Analytics - Solid Tumor | 1 | $181,633 |
| AD, Brand Reporting Solutions | 1 | $188,000 |
| AD, Marketing Data Orchestration | 1 | $187,535 |
| AD, Marketing Strategist | 1 | $186,120 |
UK sponsor licence
An organisation named Novartis Pharmaceuticals UK Ltd is on the UK Home Office register of licensed worker sponsors (13 October 2026), best rating A. The name matches exactly; a UK company can still be a separate legal entity, so check it is the same group. Routes: Global Business Mobility: Senior or Specialist Worker, Skilled Worker.
| Organisation on the register | Town | Type & rating | Routes |
|---|---|---|---|
| Novartis Pharmaceuticals UK Ltd | London | Worker (A rating) | Global Business Mobility: Senior or Specialist Worker; Skilled Worker |
How to read these numbers
- An LCA is the first step
- Before filing an H-1B, H-1B1 or E-3 petition, the employer files a labor condition application (LCA) with the Department of Labor, stating the job, worksite and the wage it will pay.
- Certified is not a visa
- A certified LCA means the Department of Labor accepted the wage attestation. It is not an approved petition or an issued visa, and it does not mean the role is still open or that the employer will sponsor you.
- Counts are applications
- One LCA can cover several workers, and employers often file more LCAs than they use (for example for the H-1B lottery or a worksite change). Read the totals as a measure of sponsorship activity, not of hires.
Questions
Does Novartis Pharmaceuticals sponsor H-1B visas?
Yes — NOVARTIS PHARMACEUTICALS CORPORATION filed 280 H-1B and E-3 labor condition applications that the US Department of Labor certified between 1 October 2023 and 30 June 2026, 75 of them in FY2026 (to 30 Jun). It also had 56 PERM labor certifications (the first step of most employer-sponsored green cards) certified in the same period.
What does Novartis Pharmaceuticals pay H-1B workers?
On its certified LCAs, NOVARTIS PHARMACEUTICALS CORPORATION's most-filed title was Principal Biostatistician (32 filings), with a median offered wage of $136,219 a year and the middle half between $112,965 and $142,771. These are wages the employer stated on the application, not actual pay.
What wage level does Novartis Pharmaceuticals file H-1B jobs at?
Most of NOVARTIS PHARMACEUTICALS CORPORATION's certified LCAs in FY2024–FY2026 were at prevailing-wage level III (37%, median offered wage $141,170 a year). By level: level I 5% (14 filings, median $96,668); level II 21% (60 filings, median $112,965); level III 37% (104 filings, median $141,170); level IV 36% (100 filings, median $169,541); no level 1% (2 filings, median $160,856). Level I is entry level and level IV is fully competent, in the Department of Labor's wage survey.
Does Novartis Pharmaceuticals sponsor green cards?
It also had 56 PERM labor certifications (the first step of most employer-sponsored green cards) certified in the same period.
Is Novartis Pharmaceuticals a licensed UK visa sponsor?
An organisation named Novartis Pharmaceuticals UK Ltd is on the UK Home Office register of licensed worker sponsors (13 October 2026), best rating A. The name matches exactly; a UK company can still be a separate legal entity, so check it is the same group.
Check any company, or get their live jobs tagged with sponsorship evidence.
Look up Novartis Pharmaceuticals alongside any other employer, or pull their open roles from Greenhouse, Lever, Ashby, Personio and Teamtailor with each job tagged by how often the employer filed for a similar title, and the wage it offered.
Hiring, not job hunting? Get a free check of whether Google and Claude mention your business. Or get the weekly list of jobs at visa-sponsoring employers, $19 a month, first week free.